OCEA

0.00040.00%
RS

Roy Steven Herbst

Member of Scientific Advisory Board

Dr. Roy Steven Herbst, MD, PhD is Scientific Advisory Board of Neuvogen, Inc. He serves as the Member of Scientific Advisory Board of Normunity Inc. and NovaBridge Biosciences. Dr. Herbst is Member of Scientific Advisory Board of Infinity Pharmaceuticals, Inc. from March 2018. Dr. Herbst joined the Infinity Pharmaceuticals, Inc. in March 2018. Dr. Herbst was Member of Scientific Advisory Board of Checkpoint Therapeutics, Inc until May 30, 2025. Dr. Herbst is Member of Scientific Advisory Board of Everist Health Inc. Dr. Herbst is Member of Research Advisory Board of Candel Therapeutics, Inc. from April 2021. Dr. Herbst joined the Candel Therapeutics, Inc. in April 2021. Dr. Herbst is Member of Scientific Advisory Board of SynDevRx Inc. Dr. Herbst is Member of Scientific Advisory Board of Kolltan Pharmaceuticals, Inc. Dr. Herbst joined the Kolltan Pharmaceuticals, Inc. in September 2013. Dr. Herbst is Member of Medical Advisory Board of Diatech Oncology, LLC. Dr. Herbst joined the Diatech Oncology, LLC in September 2012. Dr. Herbst is Independent Non-Executive Director of Immunocore Holdings plc from January 28, 2021. Dr. Herbst joined the Immunocore Holdings plc on January 28, 2021. Dr. Herbst is Member of Science & Medical Advisor of N-of-One, Inc. Dr. Herbst is Member of Clinical Advisory Board – Oncology of Damora Therapeutics, Inc. (formerly known as Galecto, Inc.) Dr. Herbst is Independent Non-Executive Director of Topalliance Biosciences Inc. Dr. Herbst is Member of Scientific Advisor Board of BioNTech US Inc. Dr. Herbst is Member of Scientific and Medical Advisory Board of BeyondSpring Pharmaceuticals, Inc. Dr. Herbst is Member of Scientific Advisory Board of Cybrexa, Inc. from August 2020. Dr. Herbst is Member of Scientific Advisory Board of CATALYM GmbH from January 2024. Dr. Herbst is Member of Scientific Advisory Board of I-Mab from July 2019. Dr. Herbst joined the I-Mab in July 2019. Dr. Herbst is Member of Scientific Advisory Board of Ocean Biomedical, Inc. Dr. Herbst is Advisory Board Member of CoRegen Inc. Dr. Herbst was Member of the Scientific Advisory Board of Monogram Biosciences, Inc. Dr. Herbst was Member of OncoAssist Advisory Board of MedTrust Online, LLC. Dr. Herbst was Member of Scientific Advisory Board of Aclara Biosciences Inc. Dr. Herbst joined the Aclara Biosciences Inc. in July 2004. Dr. Herbst was Member of Clinical Advisors of Biothera Pharmaceuticals, Inc. Dr. Herbst joined the Biothera Pharmaceuticals, Inc. in December 2008. Dr. Herbst was Director of ApoCell, Inc. Dr. Herbst was Independent Non-Executive Director of Shanghai Junshi Biosciences Co., Ltd. from June 24, 2018 to June 21, 2024. Dr. Herbst was employed at Shanghai Junshi Biosciences Co., Ltd. from June 24, 2018 to June 21, 2024. Dr. Herbst was Member of Scientific Advisory Board of Bolt Biotherapeutics, Inc. until June 2024. Dr. Herbst was employed at Bolt Biotherapeutics, Inc. until June 2024. Dr. Herbst has B.S. in Biochemistry & Molecular Biophysics from Yale University, M.S. in Biochemistry & Molecular Biophysics from Yale University, Ph.D. in Biology from Rockefeller University, M.D. from Weill Cornell Medical College, New York, Master's in Clinical Science & Medical Science from Harvard Medical School.

Positions